Medtronic obtains expanded FDA approval for cryoablation catheters
The catheters are indicated for treating paroxysmal atrial fibrillation as an early rhythm control strategy.
Cardiovascular
Circle and DiA Imaging partner on AI-based cardiovascular solutions
By adding DiA’s LVivo Toolbox, Circle CVI's product offering will extend to a comprehensive cardiovascular...
Abbott obtains CE mark for steerable delivery system for LAA occlusion
Approved for use with Abbott’s Amplatzer Amulet LAA Occluder, the system is only available in...
Medtronic to discontinue supply and marketing of HVAD
This development comes after the company received nearly 100 complaints on the delay or failure...
Abiomed acquires catheter and controller developer preCARDIA
The preCARDIA system can quickly treat ADHF-linked volume overload to improve cardiac and renal function.
Carotid artery bare metal stents avoids declining growth due to APAC regional success
The carotid artery bare metal stents (BMS) market experienced a 2.7% growth in revenue in the Asia-Pacific (APAC) region last year, despite the impacts of the Covid-19 pandemic.
New TAVR device on the market as Abbott’s Navitor system receives CE mark
Abbott Laboratories' new transcatheter aortic valve replacement (TAVR) system, Navitor, recently received regulatory approval in Europe.
Abbott’s valve system obtains CE mark for aortic stenosis treatment
Abbott’s Navitor transcatheter aortic valve implantation system receives CE mark to treat severe aortic stenosis patients.
NHS unveils 3D imaging technology to expedite heart disease diagnosis
The National Health Service England (NHS) has unveiled a new technology called HeartFlow to quickly detect and treat people with suspected heart disease.
Medtronic receives CE mark for severe aortic stenosis treatment system
Medtronic has received CE mark for its Evolut PRO+ TAVI System in Europe to treat patients with symptomatic severe aortic stenosis.
CE mark awarded to Phoenix Cardiac Devices’ BACE system
On April 28, 2021, Phoenix Cardiac Devices gained regulatory CE mark approval for its BACE (basal annuloplasty of the cardiac externally) device, for treatment of functional mitral regurgitation.
